Correlation Between NYSE Composite and Mirum Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Mirum Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Mirum Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Mirum Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Mirum Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Mirum Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Mirum Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Mirum Pharmaceuticals
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between NYSE and Mirum is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Mirum Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirum Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Mirum Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirum Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Mirum Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Mirum Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 2.04 times less return on investment than Mirum Pharmaceuticals. But when comparing it to its historical volatility, NYSE Composite is 3.89 times less risky than Mirum Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Mirum Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 4,311 in Mirum Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 354.00 from holding Mirum Pharmaceuticals or generate 8.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Mirum Pharmaceuticals
Performance |
| Timeline |
NYSE Composite and Mirum Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Mirum Pharmaceuticals
Pair trading matchups for Mirum Pharmaceuticals
Pair Trading with NYSE Composite and Mirum Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Mirum Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Mirum Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirum Pharmaceuticals will offset losses from the drop in Mirum Pharmaceuticals' long position.| NYSE Composite vs. Nextplat Corp | NYSE Composite vs. Qualys Inc | NYSE Composite vs. Cadence Design Systems | NYSE Composite vs. Asure Software |
| Mirum Pharmaceuticals vs. Immunocore Holdings | Mirum Pharmaceuticals vs. Larimar Therapeutics | Mirum Pharmaceuticals vs. Kalvista Pharmaceuticals | Mirum Pharmaceuticals vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |